🇺🇸 FDA
Patent

US 12109225

Methods for potentiating cancer treatment using ionizing radiation

granted A61KA61K31/737A61K41/0038

Quick answer

US patent 12109225 (Methods for potentiating cancer treatment using ionizing radiation) held by GLYCOMIRA THERAPEUTICS, INC. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GLYCOMIRA THERAPEUTICS, INC.
Grant date
Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/737, A61K41/0038, A61P, A61P35/00